USPTO serial 90053652
SEQ TECH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 31, 2022
- Examiner
- CHANG, ELIZABETH YI HSUAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEQ TECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Pro Bono Bio Entrepreneur Limited
Reading, Berkshire, GB
Pro Bono Bio Entrepreneur Limited
Reading, Berkshire, GB
Pro Bono Bio Entrepreneur Limited
Reading, Berkshire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David M. Perry
David M. Perry BLANK ROME LLPONE LOGAN SQUARE8TH FLOORPHILADELPHIA, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Lipids and surfactants being chemical preparations for use in industry and science; surfactants and lipids for use in personal care products; chemical products, namely, chemicals for in vitro or in vivo use in research and product development; chemical products, namely, chemicals for use in science and in research; ingredients for use in cosmetic preparations, namely, collagen and emollient; active chemical ingredients for use in the course of manufacture of pharmaceuticals for treating dermatological conditions and skincare products; active chemical ingredients for use in the course of manufacture of pharmaceuticals, namely, veterinary, dietetic, and dietary pharmaceuticals and dietary pharmaceuticals; diagnostic preparations and substances, all for scientific in vivo use; biochemical preparations of arachidonic acids for scientific purposes | ACTIVE | — |
| 003 | Toiletries, namely, non-medicated toiletry preparations; non-medicated skin care preparations; face cleansers; cosmetic preparations for skin care; serum, namely, non-medicated skin serum; beauty balms; skin balms; skin toners; exfoliators, namely, cosmetic exfoliant creams and scrubs; cosmetic eye masks; face masks, namely, beauty mask for faces; non-medicated skin toners; cosmetic skin cream, oils, lotions and sprays; skin conditioners; moisturisers, namely, skin, face, body, and hand moisturizers; eye cream; eye gel; lip moisturisers; lip balm; hand cream; body lotions; body washes; cosmetic foot balms; body scrubs; skin care kits consisting primarily of cosmetics; toiletry kits consisting primarily of cosmetics; essential oils; fragrances; non-medicated soap; hair care preparations; dentifrices; cosmetics; dispersions and dry preparations of liposomal active substance carriers for cosmetic preparations | ACTIVE | — |
| 005 | Pharmaceutical preparations and substances for treating pain and inflammation; veterinary and sanitary preparations and substances for treating pain and inflammation; chemical preparations for pharmaceutical purposes for treating pain and inflammation; diagnostic preparations and substances, all for medical and veterinary in vivo use; pharmaceuticals, namely, pharmaceutical preparations for treatment and diagnosis in the field of osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; topical and parenteral preparations in the form of vesicles for treatment of pain, inflammation, osteoarthritis, and dermatological conditions; chemical preparations in the form of vesicles for medical and veterinary purposes for treating or diagnosing pain, inflammation, osteoarthritis, and dermatological conditions; chemical membranes and chemical aggregates being chemical reagents for medical and veterinary purposes; pharmaceutical preparations of arachidonic acids; dispersions and dry preparations of liposomal active substance carriers for pharmaceutical and veterinary substances; cosmeceutical preparations for medical use, namely, pharmaceutical preparations for treating dermatological conditions; local anaesthetics; steroids; anti-inflammatory drugs; lipids for topical and parenteral use in treating dermatological conditions, namely, acne, psoriasis, eczema, rosacea, and photo- or age-damaged skin and collagen; pharmaceutical creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solution for the treatment of pain or inflammation; surfactants for use in the treatment of or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, namely, inflammatory diseases and disorders that speed the onset of arthritic disorders and syndromes, inherited disease being haematological diseases, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; surfactants for use in the treatment of or prevention of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrheic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout and macular degeneration, AMD, fungal infection, and disorders related to fatty acid deficiencies; Veterinary therapeutic preparations and therapeutic pharmaceuticals in the fields of laminitis, debilitating joint diseases, bog spavin and bone spavin, bowed tendons, capped joints, curb (inflammation of the rear cannon bone below the point of hock), laminitis, navicular disease, osselets, ringbone, sesamoiditis, shoe boil, sidebone, speedy cut (striking of the inner lower side of the knee with the opposite limb), splints; veterinary therapeutic preparations and pharmaceuticals in the fields of sprains, stocking up, stringhalt, thoroughpin (swelling of the digital flexor tendon sheath), and windpuffs (swelling around the fetlock joint), arthritis and osteoarthritis, inflammation and diseases of the central nervous system; chemical therapeutic preparations in the form of vesicles for veterinary purposes for treating pain, inflammation, osteoarthritis, and dermatological conditions; chemical membranes for veterinary purposes for treating pain, inflammation, osteoarthritis, and dermatological conditions; chemical aggregates for veterinary purposes for treating pain, inflammation, osteoarthritis, and dermatological conditions; preparations of arachidonic acids for veterinary purposes; pharmaceuticals for the treatment of hoof fungal infections; creams, dispersions, lotions, ointments, gels, solutions, sprays, lacquers and film forming solutions for the treatment of pain or inflammation; surfactants for use in the treatment of inflammatory diseases, diseases of the mouth, teeth, skin, hair and ear, eczema, psoriasis and pain; serum, namely, medicated serum for treatment of skin; medicated skin toners; medicated soap | ACTIVE | — |
| 010 | Medical devices for topical use for the treatment of pain; molecular filtering devices for medical use; medical, veterinary and surgical apparatus, instruments and devices; inhalers; injection apparatus, instruments and devices with and without needles; apparatus, instruments and devices, namely, droppers, injection devices, and tubing for dispensing medical, surgical and veterinary preparations, dispersions, creams, powders, tablets and pills; instruments and devices for the administration of therapy and prophylaxis preparations and substances, namely, droppers, injection devices, and tubing; molecular filtering devices for veterinary use; veterinary devices for the treatment of laminitis and debilitating joint diseases, bog spavin and bone spavin, bowed tendons, capped joints, curb (inflammation of the rear cannon bone below the point of hock), laminitis, navicular disease, osselets, ringbone, sesamoiditis, shoe boil, sidebone, speedy cut (striking of the inner lower side of the knee with the opposite limb), splints; veterinary devices for the treatment of sprains, stocking up, stringhalt, thoroughpin (swelling of the digital flexor tendon sheath), and windpuffs (swelling around the fetlock joint), arthritis and osteoarthritis, inflammation and diseases of the central nervous system; veterinary instruments and devices for dispensing veterinary preparations, dispersions, creams, powders, tablets and pills; veterinary devices for the administration of pain relief, therapy and prophylaxis; parts and fittings for the aforesaid; Medical devices for topical use in the treatment of dermal conditions associated with all layers of the skin, superficial and deep; instruments and devices for the administration of skin disease and aging therapy and prophylaxis preparations and substances; structural parts and fittings for all of the aforesaid; face masks for use by healthcare providers; fashion masks being sanitary face masks for protection against viral infection; Medical apparatus, instruments and devices, namely, a medical device in which vesicles act in the nature of non-pharmaceutical nanostructures dispersed in a gel and which migrate through the skin and have a physical therapeutic effect; Medical apparatus, instruments and devices, namely, a medical device in which vesicles act as a drug delivery device dispersed in a gel and which migrate through the skin to deliver a pharmaceutical that has a therapeutic effect | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pro Bono Bio Entrepreneur Limited
- Other trademarks owned by Pro Bono Bio Entrepreneur Limited
- Other trademarks owned by Pro Bono Bio Entrepreneur Limited
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named SEQ TECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 31, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 26, 2022 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Apr 26, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 16, 2022 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Mar 16, 2022 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Mar 15, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 18, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 18, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 29, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 15, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 15, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 15, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 15, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 15, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 18, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 18, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 18, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 30, 2021 | DMCC | DATA MODIFICATION COMPLETED | — |
| Jun 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 29, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 25, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2021 | ALIE | ASSIGNED TO LIE | — |
| Apr 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 3, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 20, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jul 18, 2020 | NWAP | NEW APPLICATION ENTERED | — |